19th Mar 2008 07:00
Sinclair Pharma PLC19 March 2008 Sinclair Pharma plc (the "Company") The Company was informed on 18th March 2008 that Dr. Michael Flynn, ChiefExecutive Officer, acquired 18,670 ordinary shares of 1p each in the Company ("Ordinary Shares") at 36.5 pence per share on 18th March 2008. Following this acquisition of Ordinary Shares Dr. Flynn has an interest in atotal of 9,500,958 Ordinary Shares equalling approximately 10.2 per cent. of theissued share capital in the Company. For further information please contact: Sinclair Pharma plc Tel: +44 (0) 1483 410 600 Jerry Randall, CFO This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma